Find Lawyers Today, Get Legal Help.
Home >> Legal News >> RECALLS AND SAFETY ALERTS POSSIBILITY OF PANCREATITIS IN PATIENTS TAKING BYETTA
FDA News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
RECALLS AND SAFETY ALERTS POSSIBILITY OF PANCREATITIS IN PATIENTS TAKING BYETTA
December 3, 2007
FDA is alerting healthcare professionals that Byetta (exenatide) may be associated with acute pancreatitis in some patients. Byetta is administered subcutaneously to treat type 2 diabetes.
FDA has reviewed 30 reports of acute pancreatitis in pat...Related FDA Stories:
- Recalls and Safety Alerts Recall of Abbott Troponin- I Immunoassay..
- Recalls and Safety Alerts Safety Warning on Certain Body-building Products..
- Preventing Medical Errors Preventing Malfunctions in Defibrillator Cables a..
Additional Legal Resources:
Complete the Form Below and Talk to Experienced Lawyers
